The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance

Active surveillance (AS) is a considered treatment option for men with low or very low-risk prostate cancer. However, on repeat biopsy some 25% were upgraded and recommended for active treatment. We compare the presence or absence of primary circulating prostate cells (CPCs) with the clinical pathol...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Nigel P, Reyes, Eduardo, Fuentealba, Cynthia, Aedo, Socrates, Jacob, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243134/
https://www.ncbi.nlm.nih.gov/pubmed/28144285
http://dx.doi.org/10.3332/ecancer.2017.711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243134/
https://www.ncbi.nlm.nih.gov/pubmed/28144285
http://dx.doi.org/10.3332/ecancer.2017.711

Ejemplares similares